arrow
E

Eisuke Ueshima

Eisai Co Ltd
H指数:14
被引数:732

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intraindividual comparison of photon-counting detector CT and third-generation dual-source energy-integrating detector CT in multiphasic contrast-enhanced abdominal CT

个体内比较:光子计数探测器CT与第三代双源能量积分探测器CT在多期相对比增强腹部CT中的应用

2026-03-260
OAAI
Impact of intrahepatic lesions on lesion-specific response rates in patients with hepatocellular carcinoma treated with lenvatinib or immune checkpoint inhibitors

肝内病灶对接受仑伐替尼或免疫检查点抑制剂治疗的肝细胞癌患者病灶特异性应答率的影响

HPB
IF2.4
2025-11-150
PRE
Utility of Oncological Resectability Criteria in Recurrent Hepatocellular Carcinoma After Hepatectomy

肝切除术后复发性肝细胞癌中肿瘤可切除标准的实用性

2025-11-010
OA
Peripancreatic Vascular Involvement and Gastric Varices in Autoimmune Pancreatitis: A Multicenter Retrospective Study

自身免疫性胰腺炎的胰周血管受累与胃底静脉曲张:一项多中心回顾性研究

2025-08-060
OAAI
Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study
2024-09-160
OAAI
Side branch embolization before endovascular abdominal aortic aneurysm repair to prevent type II endoleak: A prospective multicenter study

腹主动脉瘤腔内修复术前侧支栓塞预防 ⅱ 型内漏的前瞻性多中心研究

2024-09-012
PRE
Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma

肿瘤形态与阿特珠单抗联合贝伐单抗治疗晚期肝癌疗效的关系

2024-02-144
PRE
Prediction of post-hepatectomy liver failure using gadoxetic acid-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein invasion

甲氧乙酸增强磁共振成像对肝癌门静脉侵犯肝切除术后肝衰竭的预测

2020-09-0123
OAAI